The Next Ozempic Is Already Being Sold Underground
After Katie started on Ozempic, she got her hairdresser interested, too. This summer, when they saw each other again, she thought that her hairdresser had lost some weight and that she looked “so great.” “Are you still on a GLP-1?” she asked, referring to the class of blockbuster drugs that includes Ozempic and obesity meds. […]
FDA approves Wegovy weight loss pill, paving way for new GLP-1 frontier | Morning in America
The Food and Drug Administration has approved Novo Nordisk’s pill version of its Wegovy medication, a first for GLP-1 weight loss drugs. NewsNation’s Xavier Walton has the details. #Wegovy #GLP1 #Health Start your day with “Morning in America,” NewsNation’s live three-hour national morning newscast hosted by Markie Martin. Weekdays starting at 6a/5C. #MorningInAmerica NewsNation is […]
FDA approves first GLP-1 weight loss pill from Novo Nordisk
Dec 23, 2025: 4:59 a.m.: FDA approves first GLP-1 weight loss pill from Novo Nordisk The FDA has approved the first GLP-1 pill for weight loss, clearing a tablet from Novo Nordisk https://t.co/bpAHrjETVT — The Wall Street Journal (@WSJ) December 23, 2025
Novo Nordisk’s first oral GLP-1 weight-loss pill cleared for US launch
US-listed shares of the Danish company rose sharply in after-hours trading, while Lilly’s stock edged lower
Healthcare, Vol. 14, Pages 35: Prescribing Patterns and Adverse Effects of Semaglutide: A Real-World Comparative Evaluation
Healthcare, Vol. 14, Pages 35: Prescribing Patterns and Adverse Effects of Semaglutide: A Real-World Comparative Evaluation Healthcare doi: 10.3390/healthcare14010035 Authors: Abigail Whorton Samira Osman Jaspal Johal Sarah Baig Alan M. Jones Zahraa Jalal Background: Semaglutide is a Glucagon-like peptide-1 receptor agonist (GLP-1RA) used in the treatment of type 2 diabetes mellitus (T2DM) and weight management. […]
Novo Nordisk Shares Jump After FDA Approves Pill Version of Wegovy
The company expects to launch the Wegovy pill in the U.S. in early January Novo NordiskNOVO.B7.89%increase; green up pointing triangle shares climbed after U.S. regulators approved a tablet version of Ozempic and Wegovy, paving the way for the Danish drugmaker to start selling the first GLP-1 …
FDA Okays Oral Semaglutide 25 mg for Weight Management
The Wegovy pill is the first oral GLP-1 approved for obesity in the US. Medscape Medical News
Novo Nordisk says US approves first GLP-1 pill for weight loss
Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be administered in pill form for weight loss.
GLP-1 Drugs Reduce Spending at Grocery Stores and Restaurants
Cornell Univ. When Americans begin taking appetite-suppressing drugs like Ozempic and Wegovy, the changes extend well beyond the bathroom scale. According to new research, the medications…
FDA approves pill version of popular weight loss injection
The US Food and Drug Administration approved, for the first time, an oral pill version of the blockbuster weight loss drug Wegovy, opening the door to a new form of treatment that could appeal to a broader population, particularly patients who are reluctant to use needles. Until now, Wegovy has been available only as a […]